The development and optimization of an efficient conjugation process involves identifying the critical quality attributes and monitoring critical process parameters.
Srinath Thirumalairajan
Advertisement
Srinath Thirumalairajan, PhD, is senior director of GMP Manufacturing; Jesse Novak is a bioconjugation scientist at Abzena.
Articles by Srinath Thirumalairajan
Advertisement
Latest Updated Articles
QbD in the Development of ADCs with PBD Dimer WarheadsPublished: September 1st 2018 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
